Calibrating COVID-19: The Interplay of Disease Modifying Therapy and Vaccination in Patients with Multiple Sclerosis - a podcast by ReachMD

CME credits: 0.50

Valid until: 30-06-2022

Claim your CME credit at https://reachmd.com/programs/cme/calibrating-covid-19-interplay-disease-modifying-therapy-and-vaccination-patients-multiple-sclerosis/12656/

The emergence of COVID-19 has created an unprecedented medical emergency that both raises new questions and presents updated information each day. This issue is even more pressing for patients with conditions such as multiple sclerosis (MS) who have altered immune systems from both chronic illness and disease modifying therapies (DMTs). While the advent of vaccines has revived hope for a return to normal life, vaccination is not always straightforward for those on or planning to start immunosuppressive therapies such as MS DMT. In this activity, Drs. Claire Riley and Robert Bermel discuss guidance outlined by the National Multiple Sclerosis Society (NMSS) and approaches to implementing these considerations in routine practice.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD